Market Value2,461,043,000
Total Holdings88
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AKUS / Akouos Inc
DTIL / Precision BioSciences, Inc.
ARKK / ARK ETF Trust - ARK Innovation ETF Put
QURE / uniQure N.V.
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF Put
RAIN / Rain Enhancement Technologies Holdco, Inc.
AVEO / AVEO Pharmaceuticals Inc
MLTX / MoonLake Immunotherapeutics
OLMA / Olema Pharmaceuticals, Inc.
TWST / Twist Bioscience Corporation
DMTK / DermTech, Inc.
ACRS / Aclaris Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TCRR / Tcr2 Therapeutics Inc
BEAM / Beam Therapeutics Inc.
VERU / Veru Inc.
/ Cerevel Therapeutics Holdings, Inc. Warrant
EIGR / Eiger BioPharmaceuticals, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
QTNT / Quotient Ltd
IWM / iShares Trust - iShares Russell 2000 ETF Put
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
XFOR / X4 Pharmaceuticals, Inc.
MRUS / Merus N.V.
SRNE / Sorrento Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
NERV / Minerva Neurosciences, Inc.
TBPH / Theravance Biopharma, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
FMTX / Forma Therapeutics Holdings Inc
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
GOSS / Gossamer Bio, Inc.
IMRX / Immuneering Corporation
MORF / Morphic Holding, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
RPTX / Repare Therapeutics Inc.
IGMS / IGM Biosciences, Inc.
TCDA / Tricida Inc
MASS / 908 Devices Inc.
FVAM / 5:01 Acquisition Corp.
HSAQ / Health Sciences Acquisitions Corp 2
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
CCCC / C4 Therapeutics, Inc.
APTO / Aptose Biosciences Inc.
CRDF / Cardiff Oncology, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
OMER / Omeros Corporation Call
SPRY / ARS Pharmaceuticals, Inc.
RXDX / Prometheus Biosciences Inc
OTLK / Outlook Therapeutics, Inc.
HGEN / Humanigen, Inc.
BCAB / BioAtla, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
MGTA / Magenta Therapeutics Inc
INSP / Inspire Medical Systems, Inc.
AKRO / Akero Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ZYME / Zymeworks Inc.
IMAB / I-Mab - Depositary Receipt (Common Stock)
MYOV / Myovant Sciences Ltd
CHAQ / Chardan Healthcare Acquisition 2 Corp
XLRN / Acceleron Pharma Inc
TYRA / Tyra Biosciences, Inc.
RVMD / Revolution Medicines, Inc.
ALGS / Aligos Therapeutics, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
AGEN / Agenus Inc.
BCEL / Atreca, Inc.
ITOS / iTeos Therapeutics, Inc.
VECT / VectivBio Holding AG
CYTK / Cytokinetics, Incorporated
GRPH / Graphite Bio, Inc.
IMV / IMV Inc
ANAB / AnaptysBio, Inc.
HARP / Harpoon Therapeutics, Inc.
ERAS / Erasca, Inc.
ICVX / Icosavax, Inc.
AXNX / Axonics, Inc.
ATXS / Astria Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
VRDN / Viridian Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
INSM / Insmed Incorporated
PHVS / Pharvaris N.V.
STOK / Stoke Therapeutics, Inc.
BMEA / Biomea Fusion, Inc.
AVIR / Atea Pharmaceuticals, Inc.
ELEV / Elevation Oncology, Inc.
TALS / Talaris Therapeutics Inc
GLTO / Galecto, Inc.
TNGX / Tango Therapeutics, Inc.
TPTX / Turning Point Therapeutics Inc
OMER / Omeros Corporation
VERV / Verve Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
GHRS / GH Research PLC
EWTX / Edgewise Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
AMAM / Ambrx Biopharma Inc.
APLS / Apellis Pharmaceuticals, Inc.
CABA / Cabaletta Bio, Inc.
PRAX / Praxis Precision Medicines, Inc.
LBPH / Longboard Pharmaceuticals, Inc.